RESEARCH-USE BIOSIMILAR ANTIBODY
Ascrinvacumab
Monoclonal antibody · IgG2
Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody targets ALK-1. Ascrinvacumab shows binding efficiency with human ALK1 with a Kd value of 7 nM. Ascrinvacumab can be used for the research of hepatocellular carcinoma (HCC).
TARGETACVRL1
YMonoclonal antibody
CATALOGSC-BS-757
CATALOG NUMBERSC-BS-757
MOLECULAR WEIGHTApprox. 144.08 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody targets ALK-1. Ascrinvacumab shows binding efficiency with human ALK1 with a Kd value of 7 nM. Ascrinvacumab can be used for the research of hepatocellular carcinoma (HCC).
Ascrinvacumab is a recombinant research-use antibody directed against ACVRL1.